Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
ETON Eton Pharmaceuticals Inc
- Stocks
- Healthcare
- NASDAQ: ETON
Price (delayed)
$16.95
Market cap
$454.56M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.19
Enterprise value
$467.22M
Eton Pharmaceuticals, Inc. is an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases. The company currently owns or receives royalties from three FDA-approved products, including ALKINDI®
Highlights
ETON's equity has surged by 58% year-on-year
The revenue is up by 40% YoY and by 26% QoQ
The quick ratio has grown by 30% from the previous quarter but it has contracted by 2.9% YoY
ETON's EPS is down by 27% since the previous quarter
The company's net income fell by 20% QoQ
Key stats
What are the main financial stats of ETON
Market
Valuations
Earnings
Shares outstanding
26.82M
Market cap
$454.56M
Enterprise value
$467.22M
Price to earnings (P/E)
N/A
Price to book (P/B)
18.59
Price to sales (P/S)
9.22
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
9.45
Revenue
$49.42M
Gross profit
$29.36M
Operating income
-$1.17M
Net income
-$4.58M
EBIT
-$2.27M
EBITDA
-$273,000
Free cash flow
$5.52M
Per share
Balance sheet
Liquidity
EPS
-$0.19
EPS diluted
-$0.19
Free cash flow per share
$0.21
Book value per share
$0.91
Revenue per share
$1.84
TBVPS
$1.87
Total assets
$84.03M
Total liabilities
$59.58M
Debt
$30.08M
Equity
$24.45M
Working capital
$24.61M
Debt to equity
1.23
Current ratio
1.97
Quick ratio
1.33
Net debt/EBITDA
-46.37
Margins
Efficiency
Dividend
EBITDA margin
-0.6%
Gross margin
59.4%
Net margin
-9.3%
Operating margin
-2.4%
Return on assets
-8%
Return on equity
-23.4%
Return on invested capital
-14.5%
Return on capital employed
-3.9%
Return on sales
-4.6%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ETON stock price
How has the Eton Pharmaceuticals stock price performed over time
Intraday
-1.91%
1 week
-15.59%
1 month
-2.25%
1 year
370.83%
YTD
27.25%
QTD
30.59%
Financial performance
How have Eton Pharmaceuticals's revenue and profit performed over time
Revenue
$49.42M
Gross profit
$29.36M
Operating income
-$1.17M
Net income
-$4.58M
Gross margin
59.4%
Net margin
-9.3%
The operating income has plunged by 176% YoY but it has grown by 50% from the previous quarter
The company's operating margin has shrunk by 155% YoY but it has surged by 59% QoQ
The revenue is up by 40% YoY and by 26% QoQ
Eton Pharmaceuticals's gross profit has increased by 24% from the previous quarter and by 24% YoY
Price vs fundamentals
How does ETON's price correlate with its fundamentals
Growth
What is Eton Pharmaceuticals's growth rate over time
Valuation
What is Eton Pharmaceuticals stock price valuation
P/E
N/A
P/B
18.59
P/S
9.22
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
9.45
ETON's EPS is down by 27% since the previous quarter
The stock's price to book (P/B) is 67% more than its last 4 quarters average of 11.1 and 34% more than its 5-year quarterly average of 13.9
ETON's equity has surged by 58% year-on-year
ETON's P/S is 96% below its 5-year quarterly average of 253.5 but 62% above its last 4 quarters average of 5.7
The revenue is up by 40% YoY and by 26% QoQ
Efficiency
How efficient is Eton Pharmaceuticals business performance
Eton Pharmaceuticals's ROIC has soared by 68% from the previous quarter
ETON's return on sales is up by 30% since the previous quarter
The return on assets has grown by 9% since the previous quarter
Eton Pharmaceuticals's ROE has decreased by 6% from the previous quarter
Dividends
What is ETON's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ETON.
Financial health
How did Eton Pharmaceuticals financials performed over time
ETON's total assets is 41% more than its total liabilities
ETON's total assets has soared by 173% YoY and by 10% from the previous quarter
The quick ratio has grown by 30% from the previous quarter but it has contracted by 2.9% YoY
The debt is 23% greater than the equity
ETON's equity has surged by 58% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.